Perceptive Advisors - MIRATI THERAPEUTICS INC ownership

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 208 filers reported holding MIRATI THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of MIRATI THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$26,671,191
-54.4%
919,103
-41.6%
0.77%
-55.3%
Q1 2023$58,526,302
-41.1%
1,574,134
-28.2%
1.73%
-38.0%
Q4 2022$99,293,467
-48.9%
2,191,425
-21.3%
2.79%
-50.6%
Q3 2022$194,490,000
+1.1%
2,784,796
-2.9%
5.64%
-6.4%
Q2 2022$192,453,000
-1.7%
2,866,863
+20.4%
6.03%
+53.7%
Q1 2022$195,742,000
-79.7%
2,380,710
-63.8%
3.92%
-47.2%
Q4 2021$963,396,000
+60.7%
6,567,566
+93.9%
7.43%
-14.7%
Q3 2021$599,326,000
-41.8%
3,387,745
-46.8%
8.71%
+30.2%
Q2 2021$1,029,236,000
+72.9%
6,371,796
+83.4%
6.68%
-11.2%
Q1 2021$595,183,000
-26.6%
3,474,505
-5.9%
7.53%
-13.5%
Q4 2020$811,244,000
+42.2%
3,693,516
+7.5%
8.71%
+4.5%
Q3 2020$570,477,000
+80.3%
3,435,575
+24.0%
8.33%
+62.5%
Q2 2020$316,371,000
+23.9%
2,771,050
-19.0%
5.13%
-22.9%
Q1 2020$255,316,000
-38.1%
3,419,450
+6.7%
6.65%
-18.9%
Q4 2019$412,791,000
+59.8%
3,203,406
-6.2%
8.20%
+17.8%
Q3 2019$258,386,000
-13.5%
3,414,606
+17.8%
6.96%
+1.6%
Q2 2019$298,659,000
+249.9%
2,899,606
+149.0%
6.85%
+184.6%
Q1 2019$85,349,000
+1525.7%
1,164,382
+825.0%
2.41%
+1104.0%
Q4 2018$5,250,000
-85.1%
125,875
-82.4%
0.20%
-78.3%
Q2 2018$35,160,000
+3837.3%
713,191
+2351.6%
0.92%
+3588.0%
Q1 2018$893,000
+68.2%
29,0910.0%0.02%
+38.9%
Q4 2017$531,000
+26450.0%
29,091
+5483.7%
0.02%
Q4 2016$2,000
-100.0%
521
-99.8%
0.00%
-100.0%
Q1 2016$5,842,000273,0000.51%
Other shareholders
MIRATI THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Aviva Holdings Ltd. 3,135,966$136,602,67987.83%
EcoR1 Capital, LLC 5,748,399$250,400,2608.45%
Boxer Capital, LLC 3,201,440$139,454,7267.42%
RTW INVESTMENTS, LP 6,768,514$294,836,4706.22%
Paradigm Biocapital Advisors LP 1,668,116$72,663,1334.93%
Avoro Capital Advisors LLC 6,666,666$290,399,9714.53%
Octagon Capital Advisors LP 655,051$28,534,0224.38%
Artal Group S.A. 2,024,226$88,1753.78%
Ally Bridge Group (NY) LLC 70,283$3,061,5273.59%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 216,000$9,404,6403.17%
View complete list of MIRATI THERAPEUTICS INC shareholders